Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 6/20 | 0.60 |
| ▸ | DYRK1A | Q13627 | 7/20 | 0.57 |
| ▸ | CLK4 | Q9HAZ1 | 7/20 | 0.57 |
| ▸ | CDK2 | P24941 | 5/20 | 0.57 |
| ▸ | CLK1 | P49759 | 5/20 | 0.57 |
| ▸ | CLK2 | P49760 | 6/20 | 0.53 |
| ▸ | DYRK1B | Q9Y463 | 4/20 | 0.53 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.52 |
| ▸ | GSK3B | P49841 | 4/20 | 0.51 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.51 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.50 |
| ▸ | PKN2 | Q16513 | 2/20 | 0.50 |
| ▸ | BRSK1 | Q8TDC3 | 2/20 | 0.50 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.50 |
| ▸ | STK17A | Q9UEE5 | 2/20 | 0.50 |
| ▸ | DYRK3 | O43781 | 2/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24137561 | 0.90 | ROCK2 (0.63) | FGFR1DYRK1ACLK4CDK2CLK1 | |
| SCHEMBL24137515 | 0.82 | RPS6KB1 (0.52) | DYRK1ACLK4CDK2CLK1CLK2 | |
| SCHEMBL25934074 | 0.82 | CLK4 (0.50) | FGFR1DYRK1ACLK4CDK2CLK1 | |
| SCHEMBL22191705 | 0.82 | BACE1 (0.54) | FGFR1DYRK1ACLK4CDK2CLK1 | |
| SCHEMBL24137530 | 0.81 | FGFR1 (0.56) | FGFR1DYRK1ACLK4CDK2CLK1 | |
| SCHEMBL24137787 | 0.78 | JAK2 (0.61) | FGFR1CDK2MKNK2MKNK1GSK3B | |
| SCHEMBL22191095 | 0.77 | PLK4 (0.50) | DYRK1ACLK4CDK2MKNK2GSK3B | |
| SCHEMBL2460902 | 0.76 | FGFR1 (1.00) | FGFR1DYRK1ACLK4CDK2CLK1 | |
| SCHEMBL22190928 | 0.76 | NPC1 (0.55) | DYRK1ACLK4CDK2CLK1CLK2 | |
| SCHEMBL24137535 | 0.76 | PKM (0.52) | DYRK1ACLK4CDK2CLK2MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-07-27 | — | — | US | disclosed |
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-07-27 | — | — | US | disclosed |
| WO-2021263129-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234935-A1 | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | PACSIN2, MAP3K20, PHKG1 | FGFR1 600/4885DYRK1A 495/4885CLK4 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.